KCT0000925已完成未知
A Phase 2, Randomized, Double-blind, Parallel, Placebo-controlled, Multi-center Study to Compare Efficacy and Safety between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients
Yonsei University Health System, Gangnam Severance Hospital0 个研究点目标入组 96 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 60(Year)（—）
- 性别
- All
入选标准
- •1.Subjects who have ability to comprehend the contents of study and before participating in trial and have willingness to sign of informed consent in writing
- •3.20= age =60
- •4.A patient has symptom of acute low back pain 4= VAS
排除标准
- •1.Subjects who cannot prohibit anti-inflammatory drug, painkiller or muscle relaxants during clinical trial
- •2.Chronic rheumatoid arthritis patients
- •3.Patients having a medical history of hypersensitivity to Eperisone Hydrochloride
- •4.Subject having a hereditary problem such as galactose intolerance, Lapp lactase deficiency, or glucose galatose malabsorption
- •5.Participation in other studies before 60 days of first dosing
- •6.Female patients having positive pregnancy test, lactating women,planning pregnancy during clinical trial
- •7.Inadequate subject for the clinical trial by the investigator's decision
研究者
相似试验
招募中
1 期
Study of M5049 in DM and PM Participants (NEPTUNIA)CTIS2022-501351-82-00Merck Healthcare KGaA41
已完成
2 期
A Phase IIa, Randomised, Parallel, Double-Blind,Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MEDI0382 in Japanese Preobese or Obese Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control with Diet and ExerciseType 2 DiabetesJPRN-jRCT2080224025AstraZeneca KK60
进行中（未招募）
不适用
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgiaPosttraumatic Neuralgia (neuropathic pain)MedDRA version: 14.1Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-019785-90-SEAstraZeneca AB135
进行中（未招募）
1 期
A Phase IIa, Double-blind, Randomised, Parallel-group, Multi-centre Study to Evaluate the Analgesic Efficacy of 28 Days Oral Administration of AZD2423 Compared to Placebo in Patients with Posttraumatic NeuralgiaPosttraumatic Neuralgia (neuropathic pain)MedDRA version: 12.1Level: LLTClassification code 10054095Term: Neuropathic painEUCTR2010-019785-90-FRAstraZeneca AB135
进行中（未招募）
不适用
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgiaPosttraumatic Neuralgia (neuropathic pain)MedDRA version: 14.0Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-019785-90-GBAstraZeneca AB135